IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients wit...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
1 May 2020
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated m...
Prof Alain Algazi -University of California San Francisco, San Francisco, USA
30 Apr 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
27 Jan 2020
The treatment landscape of occular melanoma
Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada
21 Oct 2019
IMspire170: New combination treatment for advanced melanoma
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
7 Oct 2019
CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanom...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
7 Oct 2019
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
30 Sep 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Latest updates in melanoma research
Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlan...
21 Mar 2019
Education and innovation in surgical oncology
Prof Riccardo Audisio - Sahlgrenska University Hospital, Göteborg, Sweden
23 Jan 2019
The Central Malignant Melanoma Registry in Germany
Prof Ulrike Leiter-Stöppke - University of Tübingen, Tübingen, Germany
23 Nov 2018
Melanoma incidence: signs for a decline?
Prof David Whiteman - QIMR Berghofer Medical Research Institute, Brisbane, Austr...
22 Nov 2018
